Artivion (AORT) Research & Development (2010 - 2026)
Artivion posted quarterly Research & Development of $8.8 million for Q1 2026, up 31.41% year-on-year from $6.7 million in Q1 2025, and down 3.08% on a QoQ basis from $9.1 million in Q4 2025.
Artivion (AORT) has 17 years of Research & Development data on file, last reported at $8.8 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development rose 31.41% year-over-year to $8.8 million; the trailing twelve-month figure through Mar 2026 stood at $33.1 million (up 17.25% YoY), and the FY2025 full-year result was $31.0 million, up 8.92% from the prior year.
- Research & Development for Q1 2026 stood at $8.8 million, down from $9.1 million in the prior quarter.
- Across five years, Research & Development topped out at $11.8 million in Q3 2022 and bottomed at $6.4 million in Q3 2023.
- The 5-year median for Research & Development is $7.5 million (2024), against an average of $8.0 million.
- The widest annual swing landed in 2023, when Research & Development plunged 45.58%; it then jumped 31.41% in 2026.
- A 5-year view of Research & Development shows it stood at $8.3 million in 2022, then fell by 7.94% to $7.6 million in 2023, then retreated by 3.15% to $7.4 million in 2024, then increased by 23.2% to $9.1 million in 2025, then dropped by 3.08% to $8.8 million in 2026.
- The last three Research & Development figures came in at $8.8 million (Q1 2026), $9.1 million (Q4 2025), and $8.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Artivion | 1.02 Bn | 961.00 Mn | 75.45 Mn | 8.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.84 Mn |
| Dec 31, 2025 | 9.12 Mn |
| Sep 30, 2025 | 8.08 Mn |
| Jun 30, 2025 | 7.06 Mn |
| Mar 31, 2025 | 6.73 Mn |
| Dec 31, 2024 | 7.40 Mn |
| Sep 30, 2024 | 6.61 Mn |
| Jun 30, 2024 | 7.50 Mn |
| Mar 31, 2024 | 6.95 Mn |
| Dec 31, 2023 | 7.65 Mn |
| Sep 30, 2023 | 6.42 Mn |
| Jun 30, 2023 | 7.42 Mn |
| Mar 31, 2023 | 7.22 Mn |
| Dec 31, 2022 | 8.30 Mn |
| Sep 30, 2022 | 11.80 Mn |
| Jun 30, 2022 | 8.65 Mn |
| Mar 31, 2022 | 10.13 Mn |
| Dec 31, 2021 | 9.46 Mn |
| Sep 30, 2021 | 9.97 Mn |
| Jun 30, 2021 | 8.36 Mn |
| Mar 31, 2021 | 7.75 Mn |
| Dec 31, 2020 | 6.57 Mn |
| Sep 30, 2020 | 5.76 Mn |
| Jun 30, 2020 | 5.52 Mn |
| Mar 31, 2020 | 6.36 Mn |
| Dec 31, 2019 | 5.31 Mn |
| Sep 30, 2019 | 6.26 Mn |
| Jun 30, 2019 | 5.84 Mn |
| Mar 31, 2019 | 5.55 Mn |
| Dec 31, 2018 | 6.78 Mn |
| Sep 30, 2018 | 5.23 Mn |
| Jun 30, 2018 | 5.72 Mn |
| Mar 31, 2018 | 5.37 Mn |
| Dec 31, 2017 | 6.36 Mn |
| Sep 30, 2017 | 4.28 Mn |
| Jun 30, 2017 | 4.73 Mn |
| Mar 31, 2017 | 4.09 Mn |
| Dec 31, 2016 | 3.84 Mn |
| Sep 30, 2016 | 3.71 Mn |
| Jun 30, 2016 | 3.28 Mn |
| Mar 31, 2016 | 2.61 Mn |
| Dec 31, 2015 | 2.54 Mn |
| Sep 30, 2015 | 2.96 Mn |
| Jun 30, 2015 | 2.68 Mn |
| Mar 31, 2015 | 2.25 Mn |
| Dec 31, 2014 | 2.09 Mn |
| Sep 30, 2014 | 1.90 Mn |
| Jun 30, 2014 | 2.20 Mn |
| Mar 31, 2014 | 2.50 Mn |
| Dec 31, 2013 | 2.48 Mn |
| Sep 30, 2013 | 2.25 Mn |
| Jun 30, 2013 | 1.74 Mn |
| Mar 31, 2013 | 1.99 Mn |
| Dec 31, 2012 | 2.07 Mn |
| Sep 30, 2012 | 1.83 Mn |
| Jun 30, 2012 | 1.67 Mn |
| Mar 31, 2012 | 1.69 Mn |
| Dec 31, 2011 | 1.80 Mn |
| Sep 30, 2011 | 1.69 Mn |
| Jun 30, 2011 | 1.64 Mn |
| Mar 31, 2011 | 1.77 Mn |
| Dec 31, 2010 | 1.80 Mn |
| Sep 30, 2010 | 1.59 Mn |
| Jun 30, 2010 | 1.24 Mn |